Edward L. Salerno

Pulmonary Medicine

400 8th St N
Naples, FL 34102

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5 publications

Bronchopulmonary disposition of IV cefepime/taniborbactam (2-0.5 g) administered over 2 h in healthy adult subjects.

Bronchopulmonary disposition of IV cefepime/taniborbactam (2-0.5 g) administered over 2 h in healthy adult subjects.

Journal: The Journal of antimicrobial chemotherapy

Published: October 03, 2022

Selexipag, an Oral Prostacyclin-Receptor Agonist for Pulmonary Arterial Hypertension.

Selexipag, an Oral Prostacyclin-Receptor Agonist for Pulmonary Arterial Hypertension.

Journal: The Annals of pharmacotherapy

Published: May 09, 2017

An Unusual Cause of a Solitary Lung Cavity.

An Unusual Cause of a Solitary Lung Cavity.

Journal: Connecticut medicine

Published: February 18, 2016

Phase I, open-label, safety and pharmacokinetic study to assess bronchopulmonary disposition of intravenous eravacycline in healthy men and women.

Phase I, open-label, safety and pharmacokinetic study to assess bronchopulmonary disposition of intravenous eravacycline in healthy men and women.

Journal: Antimicrobial agents and chemotherapy

Published: January 29, 2014

Pulmonary disposition of tedizolid following administration of once-daily oral 200-milligram tedizolid phosphate in healthy adult volunteers.

Pulmonary disposition of tedizolid following administration of once-daily oral 200-milligram tedizolid phosphate in healthy adult volunteers.

Journal: Antimicrobial agents and chemotherapy

Published: February 15, 2012

Showing 1-5 of 5

Last Updated: 09/26/2026